Modes of preparative chromatography

Process Scale Bioseparations for the Biopharmaceutical Industry

Volumn , Issue , 2006, Pages 179-225

  Shukla, Abhinav A ^a   Yigzaw, Yinges ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85123428403     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (93)

1. Guiochon G, Shirazi SG, and Katti A. Fundamentals of Preparative and Nonlinear Chromatography. New York: Academic Press, 1994.
2. Narayanan S. Preparative affinity chromatography of proteins. Journal of Chromatography A 1994; 658:237-258.
3. Scopes R. Protein Purification - Principles and Practice, 3rd ed. New York: Springer-Verlag, 1994.
4. Burnouf T. Chromatography in plasma fractionation: Benefits and future trends. Journal of Chromatography B 1995; 664:3-15.
5. Burnouf T and Radosevich M. Affinity chromatography in the industrial purification of plasma proteins for therapeutic use. Journal of Biochemical Biophysics Methods 2001; 49:575-586.
6. Curling J. Affinity chromatography - from textile dyes to synthetic ligands by design: Part I. Biopharm 2004; 7:34-42.
7. Curling J. Affinity chromatography - from textile dyes to synthetic ligands by design: Part II. Biopharm 2004; 8:60-66.
8. Gunzer G and Hennrich N. Purification of AT-proteinase inhibitor by triazine dye affinity chromatography, ion exchange chromatography and gel filtration on Fractogel TSK. Journal of Chromatography 1984; 296: 221-229.
9. Yarmush M, Weiss A, Antonsen K, Odde D, and Yarmush D. Immunoaffinity purification: Basic principles and operational considerations. Biotechnology Advances 1992; 10:413-446.
10. Burgess R and Thompson N. Advances in gentle immunoaffinity chromato-graphy. Current Opinion in Biotechnology 2002; 13:304-308.
11. Lowe CR, Burton SJ, Burton N, Alderton W, Pitts J, and Thomas J. Designer dyes: Biomimetic ligands for the purification of pharmaceutical proteins. Tibtech 1992; 10:442-448.
12. Clonis YD, Labrou NE, Kotsira VP, Mazitsos C, Melissis S, and Gogolas G. Biomimetic dyes as affinity chromatography tools in enzyme purification. Journal of Chromatography A 2000; 891:33-44.
13. Lowe CR. Combinatorial approaches to affinity chromatography. Current Opinion in Chemical Biology 2001; 5:248-256.
14. Li R, Dowd V, Stewart D, Burton S, and Lowe CR. Design, synthesis and application of a Protein A mimetic. Nature Biotechnology 1998; 16:190-195.
15. Tribbick G, Triantafyllou B, Lauricella R, Rodda S, Mason T, and Geysen H. Systematic fractionation of serum antibodies using multiple antigen homologous peptides as affinity ligands. Journal of Immunological Methods 1991; 139:155-166.
16. Cwirla SE, Peters EA, Barrett RW, and Dower WJ. Peptides on phage: A vast library of peptides for identifying ligands. Proceedings of the National Academy of Science USA 1990; 87:6378-6382.
17. Maclennan J. Engineering microprotein ligands for large-scale affinity purification. BioTechnology 1995; 13:1180-1184.
18. Reynolds G and Millner P. Synthetic peptides as affinity ligands. In: Millner PA, Ed. High Resolution Chromatography - APractical Approach. Oxford, UK: Oxford University Press, 1999, pp. 191-215.
19. Romig T, Bell C, and Drolet D. Aptamer affinity chromatography: Combinatorial chemistry applied to protein purification. Journal of Chromatography B 1999; 731:275-284.
20. Smith JC, Derbyshire RB, Cook E, Dunthorne L, Viney J, Brewer SJ, Sassenfeld HM, and Bell LD. Chemical synthesis and cloning of a poly(arginine) coding gene fragment designed to aid polypeptide purification. Gene 1984; 32:321-327.
21. Ford CF, Suominen I, and Glatz CE. Fusion tails for the recovery and purification of recombinant proteins. Protein Expression and Purification 1991; 2:95-107.
22. Wood D, Wu W, Belfort G, Derbyshire V, and Belfort M. A genetic system to modulate intein function for use in biotechnology. Nature Biotechnology 1999; 17:889-892.
23. Drager RR and Regnier FE. Application of the stoichiometric displacement model of retention to anion-exchange chromatography of nucleic acids. Journal of Chromatography 1986; 359:147-155.
24. Brooks CA and Cramer SM. Steric mass action ion exchange displacement profiles and induced salt gradients. AIChE Journal 1992; 38:1969-1978.
25. Gadam SD, Jayaraman G, and Cramer SM. Characterization of non-linear adsorption properties of dextran-based polyelectrolyte displacers in IEX systems. Journal of Chromatography 1993; 630:37-52.
26. Stahlberg J. Retention models for ions in chromatography. Journal ofChroma-tographyA 1999; 855:3-55.
27. Arshady R. Beaded polymer supports and gels II. Physicochemical criteria and functionalization. Journal of Chromatography 1991; 586:199-219.
28. Boschetti E. Advanced sorbents for preparative protein separation purposes. Journal ofChromatography A1994; 658:207-236.
29. Weaver LE and Carta G. Protein adsorption on cation-exchangers: Comparison of macroporous and gel-composite media. Biotechnology Progress 1996; 12:342-355.
30. Muller W. New ion exchangers for the chromatography of biopolymers. Journal of Chromatography 1990; 510:133-140.
31. Afeyan NB, Gordon NF, Mazsaroff I, Varady L, Fulton SP, Yang YB, and Regnier FE. High-performance liquid chromatographic separation of flow-through particles for the biomolecules: perfusion chromatography. Journal of Chromatography 1990; 519:1-29.
32. Hunter AK and Carta G. Protein adsorption on novel acrylamido based polymeric ion exchangers I: Morphology and equilibrium adsorption. Journal of Chromatography A 2000; 897:65-80.
33. Hunter AK and Carta G. Protein adsorption on novel acrylamido based polymeric ion exchangers II: Adsorption rates and column behavior. Journal of Chromatography A 2000; 897:81-97.
34. Gustavsson PE and Larsson PE. Superporous agarose, a new material for chromatography. Journal ofChromatography A 1996; 734:231-240.
35. van Reis R. Charge Exclusion Phenomena in Separation Media. American Chemical Society National Meeting, San Diego, CA, March 2005.
36. Ghose S, McNerney TM, and Hubbard B. pH transitions in ion-exchange systems: Role in the development of a cation-exchange process for a recombinant protein. Biotechnology Progress 2002; 18:530-537.
37. Kang X and Frey DD. Chromatofocusing of peptides and proteins using linear pH gradients formed on strong IEXsorbents. Biotechnology and Bioengineering 2004; 87:376-387.
38. Gagnon P, Godfrey B, and Ladd D. A method forobtaining unique selectivities in IEX by the addition of organic polymers to the mobile phase. Journal of Chromatography 1996; 743:51-55.
39. Curtis S, Lee K, Blank GS, Brorson K, and Xu Y. Generic/matrix evaluation of SV40 clearance by anion-exchange chromatography in the flowthrough mode. Biotechnology and Bioengineering 2003; 84:179-186.
40. Shaltiel S and Er-el Z. Hydrophobic chromatography: Use for purification of glycogen synthetase. Proceedings of the National Academy of Science USA 1973; 70:778-781.
41. Hjerten S. Some general aspects of HIC. Journal of Chromatography 1973; 87:325-331.
42. Shansky RE, Wu SL, Figueroa A, and Karger BL. Hydrophobic interaction chromatography of biopolymers. In: Gooding K and Regnier F, Eds. HPLC of Biological Macromolecules, Vol. 51. Chromatographic Science Series. New York: Marcel Dekker, 1990, pp. 95-14.
43. El Rassi Z, Lee A, and Horvath Cs. Reversed-phase and hydrophobic interaction chromatography of peptides and proteins. Bioprocess Technology 1990; 9:447-494.
44. Quioroz JA, Tomaz CT, and Cabral J. Hydrophobic interaction chromatography of proteins. Journal of Biotechnology 2001; 87:143-159.
45. Ingraham R. Hydrophobic interaction chromatography of proteins. In: Mant CT and Hodges RS, Eds. High Performance Liquid Chromatography of Peptides and Proteins. New York: CRC Press, 1991, pp. 425-435.
46. Wu SL and Karger B. Hydrophobic interaction chromatography of proteins. Methods in Enzymology 1996; 270:27-47.
47. Kato Y. High-performance HIC of proteins. In: Giddings JC and Keller RA, Eds. Advances in Chromatography, Vol. 1. New York: Marcel Dekker, 1987, pp. 97-115.
48. Horvath Cs, Melander W, and Molnar I. Solvophobic interaction in liquid chro-matography with nonpolar stationary phases. Journal of Chromatography 1976; 125:129-156.
49. Antia FD and Horvath Cs. Gradient elution in non-linear preparative chroma-tography. Journal of Chromatography 1989; 484:1-27.
50. Roettger BF, Myers JA, Ladisch MR, and Regnier FE. Adsorption phenomena in HIC. Biotechnology Progress 1989; 5:79-88.
51. Arakawa T and Timasheff S. Preferential interactions of proteins with salts in concentrated solutions. Biochemistry 1982; 21:6545-6552.
52. Arakawa T and Timasheff S. Mechanism of protein salting in and salting out by divalent cation salts: Balance between hydration and salt binding. Biochemistry 1984; 23:5912-5923.
53. Vailaya A and Horvath Cs. Retention thermodynamics in HIC. Industrial and Chemical Engineering Research 1996; 35:2964-2981.
54. Gagnon P, Grund E, and Lindback T. Large scale process development for HIC Part I: Gel selection and development of binding conditions. Biopharm 1995; 8:21-29.
55. Wu SL, Figueroa A, and Karger B. Protein conformational effects in HIC - retention characteristics and the role of mobile phase additives and stationary phase hydrophobicity. Journal ofChromatography 1986; 371:3-27.
56. Mant CT and Hodges RS. Effect of HPLC solvents and hydrophobic matrices on denaturation of proteins. In: Mant CT and Hodges RS, Eds. High Performance Liquid Chromatography of Peptides and Proteins. New York: CRC Press, 1991, pp. 437-475.
57. Tibbs TL and Fernandez E. A lactalbumin tertiary structure changes on HIC surfaces. Journal of Colloid and Interface Science 2003; 259:27-35.
58. Gagnon P and Grund E. Large scale process development for HIC Part IV: Controlling selectivity. Biopharm 1996; 9:55-64.
59. Shukla AA, Sorge L, Peterson J, Lewis P, and Waugh S. Preparative purification of a recombinant protein by HIC: Modulation of selectivity by the use of chaotropic additives. Biotechnology Progress 2002; 18:556-564.
60. Gagnon P. Use of HIC with a non-salt buffer system for improving process economics in purification of monoclonal antibodies. Waterside Conference on Monoclonal and Recombinant Antibodies, Miami, FL, April 30-May 3, 2000.
61. Molnar I and Horvath Cs. Separation of amino acids and peptides on non-polar stationary phases by HPLC. Journal of Chromatography 1977; 142:623-640.
62. Huang J and Guiochon G. Applications of preparative HPLC to the separation and purification of peptides and proteins. Journal of Chromatography 1989; 492:431-469.
63. Vailaya A. Fundamentals of reversed-phase chromatography: Thermodynamic and extrathermodynamic treatment. Journal of Liquid Chromatography and Related Technologies 2005; 28:965-1054.
64. Benedek K, Dong S, and Karger B. Kinetics of unfolding of proteins on hydrophobic surfaces in RPC. Journal of Chromatography 1984; 317:227-243.
65. Lu P, Carr D, Chadwick P, Li M, and Harrison K. Process purification of polypeptides and proteins by reversed phase column chromatography: Misconceptions and reality. Biopharm 2001; 14:28-35.
66. Kroeff E, Owens R, Campbell E, Johnson R, and Marks H. Production scale purification of biosynthetic human insulin by reversed-phase HPLC. Journal of Chromatography 1989; 461:45-61.
67. Olson C, Reifsnyder D, Canova-Davis E, Ling V, and Builder S. Preparative isolation of recombinant human IGF-1 by reversed-phase HPLC. Journal of Chromatography 1994; 675:101-112.
68. Kawasaki T. Hydroxyapatite as a liquid chromatographic packing. Journal of Chromatography 1991; 544:147-184.
69. Gagnon P. Hydroxyapatite chromatography. In: Gagnon P, Ed. Purification Tools for Monoclonal Antibodies. Tucson: Validated Biosystems, 1996, pp. 87-102.
70. Sulkowski E. Purification of proteins by IMAC. Trends in Biotechnology 1985; 3:1-7.
71. Yip TT and Hutchens TW. Immobilized metal ion affinity chromatography. Molecular Biotechnology 1994; 1:151-164.
72. Wong JW, Albright RL, and Wang NHL. IMAC - chemistry and bioseparation applications. Separation and Purification Methods 1991; 20:49-106.
73. Johnson RD and Arnold FH. Multipoint binding and heterogeneity in IMAC. Biotechnology and Bioengineering 1995; 48:437-443.
74. Wirth HJ, Unger KK, and Hearn MTW. Influence of ligand density on the properties of metal-chelate affinity supports. Analytical Biochemistry 1993; 208:16-25.
75. Gaberc-Porekar V and Menart V. Perspectives of IMAC. Journal of Biochemical Biophysics Methods 2001; 49:335-360.
76. Ueda EKM, Gout PW, and Morganti L. Current and prospective applications of metal ion-protein binding. Journal of Chromatography A 2003; 988:1-23.
77. Vunnum S, Galant SR, Kim YJ, and Cramer SM. Immobilized metal affinity chromatography - modeling of nonlinear multicomponent equilibrium. Chemical Engineering Science 1995; 11:1785-1803.
78. Botros HG. Thiophilic interaction chromatography: Principles and applications. IJBC 1999; 4:209-220.
79. Porath J and Belew M. Thiophilic interaction and the selective adsorption of proteins. Tibtech 1987; 5:225-229.
80. Scholz G, Wippich P, Leistner S, and Huse K. Salt independent binding of antibodies from human serum to heterocyclic ligands. Journal of Chromatography B 1998; 709:189-196.
81. Boschetti E. The use of thiophilic chromatography for antibody purification: A review. Journal ofBiochemical Biophysical Methods 2001; 49:361-389.
82. Burton SC and Harding D. HCIC: Salt independent protein adsorption and facile elution with aqueous buffers. Journal of Chromatography A 1998; 814:71-81.
83. Schwartz W, Judd D, Wysocki M, Guerrier L, Birck-Wilson E, and Boschetti E. Comparison of HCIC with Protein A affinity chromatography for harvest and purification of antibodies. Journal of Chromatography A 2001; 908:251-263.
84. Boschetti E. Antibody separation by HCIC. Trends in Biotechnology 2002; 20:333-337.
85. Ghose S, Hubbard B, and Cramer SM. Protein interactions in HCIC. Biotechnology Progress 2005; 21:498-508.
86. Weatherly G, Bouvier A, Lydiard D, Chapline J, Henderson I, Schrimsher J, and Shepard S. Initial purification of recombinant botulinum neurotoxin fragments for pharmaceutical production using HCIC. Journal of Chromatography A 2002; 952:99-110.
87. Nau DR. Optimization of mobile phase conditions for antibody purification on a mixed mode chromatographic matrix. BioChromatography 1989; 4:131-143.
88. Johansson BL, Belew M, Eriksson S, Glad G, Lind O, Maloisel JL, and Norrman N. Preparation and characterization of prototypes for multi-modal separation media aimed for capture of negatively charged biomolecules under high salt conditions. Journal of Chromatography A 2003; 1016:21-33.
89. Johansson BL, Belew M, Eriksson S, Glad G, Lind O, Maloisel JL, and Norrman N. Preparation and characterization of prototypes for multi-modal separation media aimed for capture of positively charged biomolecules under high salt conditions. Journal ofChromatography A2003; 1016:35-49.
90. Reifsnyder DH, Olson CV, Etcheverry T, Prashad H, and Builder SE. Purification of IGF-1 and related proteins using underivatized silica. Journal of Chromatography A 1996; 753:73-80.
91. Nawrocki J. The silanol group and its role in liquid chromatography. Journal of Chromatography A 1997; 779:29-71.
92. Ghose S, McNerney T, and Hubbard B. Preparative protein purification on underivatized silica. Biotechnology and Bioengineering 2004; 87:413-423.
93. Hagel L. Size exclusion chromatography. In: Janson JC and Ryden L, Eds. Protein Purification: Principles, High Resolution Methods and Applications. New York: VCH Publishers, 1989.